Chemed Return on Tangible Equity 2010-2024 | CHE

Current and historical return on tangible equity values for Chemed (CHE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Chemed Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-03-31 $0.28B $0.50B 72.84%
2023-12-31 $0.27B $0.43B 86.97%
2023-09-30 $0.24B $0.34B 104.27%
2023-06-30 $0.23B $0.28B 142.59%
2023-03-31 $0.24B $0.20B 266.30%
2022-12-31 $0.25B $0.12B 716.55%
2022-09-30 $0.26B $0.04B -2495.24%
2022-06-30 $0.28B $0.00B 11080.00%
2022-03-31 $0.27B $-0.02B 570.21%
2021-12-31 $0.27B $-0.06B 243.44%
2021-09-30 $0.31B $0.09B 173.52%
2021-06-30 $0.30B $0.18B 168.65%
2021-03-31 $0.33B $0.24B 222.67%
2020-12-31 $0.32B $0.21B 378.70%
2020-09-30 $0.27B $0.10B 697.44%
2020-06-30 $0.26B $0.05B 5009.52%
2020-03-31 $0.23B $-0.02B 7733.33%
2019-12-31 $0.22B $0.02B 2210.00%
2019-09-30 $0.21B $-0.03B 2786.67%
2019-06-30 $0.20B $0.04B 883.52%
2019-03-31 $0.21B $0.01B 1108.11%
2018-12-31 $0.21B $0.01B 2157.89%
2018-09-30 $0.21B $0.03B 2423.53%
2018-06-30 $0.19B $0.02B -1727.27%
2018-03-31 $0.11B $-0.03B -318.31%
2017-12-31 $0.10B $0.01B -274.13%
2017-09-30 $0.08B $-0.05B -193.55%
2017-06-30 $0.07B $-0.08B -184.83%
2017-03-31 $0.11B $-0.03B -335.29%
2016-12-31 $0.11B $-0.00B -286.84%
2016-09-30 $0.11B $-0.04B -262.58%
2016-06-30 $0.11B $-0.07B -267.48%
2016-03-31 $0.11B $-0.04B -300.00%
2015-12-31 $0.11B $-0.01B -294.04%
2015-09-30 $0.11B $-0.04B -213.46%
2015-06-30 $0.11B $-0.05B -165.25%
2015-03-31 $0.10B $-0.05B -144.95%
2014-12-31 $0.10B $-0.07B -125.79%
2014-09-30 $0.09B $-0.09B -115.53%
2014-06-30 $0.09B $-0.08B -103.66%
2014-03-31 $0.08B $-0.08B -104.47%
2013-12-31 $0.08B $-0.08B -121.74%
2013-09-30 $0.08B $-0.10B -130.65%
2013-06-30 $0.09B $-0.04B -170.00%
2013-03-31 $0.09B $-0.04B -158.26%
2012-12-31 $0.09B $-0.07B -128.99%
2012-09-30 $0.09B $-0.05B -113.18%
2012-06-30 $0.09B $-0.07B -101.14%
2012-03-31 $0.09B $-0.09B -114.29%
2011-12-31 $0.09B $-0.11B -125.55%
2011-09-30 $0.08B $-0.09B -148.88%
2011-06-30 $0.08B $-0.03B -309.43%
2011-03-31 $0.08B $-0.05B -450.00%
2010-12-31 $0.08B $-0.05B -1093.33%
2010-09-30 $0.08B $0.03B -4400.00%
2010-06-30 $0.08B $0.01B -348.84%
2010-03-31 $0.07B $-0.01B -176.97%
2009-12-31 $0.07B $-0.03B -116.80%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.208B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00